ARA-290
Erythropoietin-derived peptide studied for tissue protection and neuropathic pain research.
Testing & quality
Every batch is supplier-tested for identity and purity and randomly verified by independent third-party HPLC and mass spectrometry.
Compound classification
11-amino-acid peptide derived from the helix-B domain of erythropoietin (also known as Cibinetide).
Mechanism studied in the literature
Selectively engages the innate-repair receptor (heteromer of EPOR + βcR) without activating classical erythropoietic signaling. Studied for cytoprotective and anti-inflammatory effects in preclinical models.
Research areas
- Neuropathic and inflammatory pain research (animal models)
- Tissue protection / ischemia-reperfusion studies
- Innate-repair receptor pharmacology
- Diabetic neuropathy preclinical work
Storage
Lyophilized: -20°C, protected from light. Reconstituted: 2-8°C, use within 28 days.
Reconstitution (laboratory)
Reconstitute with bacteriostatic or sterile water for injection (USP grade).
Related research peptides
BPC-157
Body protection compound studied for tissue repair, tendon healing, and gastrointestinal protection.
TB-500
Synthetic Thymosin Beta-4 fragment researched for muscle, tendon, and ligament regeneration.
GHK-Cu
Copper peptide researched for skin regeneration, wound healing, and anti-aging pathways.
KPV
Alpha-MSH tripeptide studied for anti-inflammatory and gut-barrier research applications.